180 related articles for article (PubMed ID: 16600940)
1. Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy.
Sheu BS; Cheng HC; Kao AW; Wang ST; Yang YJ; Yang HB; Wu JJ
Am J Clin Nutr; 2006 Apr; 83(4):864-9. PubMed ID: 16600940
[TBL] [Abstract][Full Text] [Related]
2. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori.
Wang KY; Li SN; Liu CS; Perng DS; Su YC; Wu DC; Jan CM; Lai CH; Wang TN; Wang WM
Am J Clin Nutr; 2004 Sep; 80(3):737-41. PubMed ID: 15321816
[TBL] [Abstract][Full Text] [Related]
3. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy.
Deguchi R; Nakaminami H; Rimbara E; Noguchi N; Sasatsu M; Suzuki T; Matsushima M; Koike J; Igarashi M; Ozawa H; Fukuda R; Takagi A
J Gastroenterol Hepatol; 2012 May; 27(5):888-92. PubMed ID: 22098133
[TBL] [Abstract][Full Text] [Related]
4. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.
Sheu BS; Wu JJ; Lo CY; Wu HW; Chen JH; Lin YS; Lin MD
Aliment Pharmacol Ther; 2002 Sep; 16(9):1669-75. PubMed ID: 12197847
[TBL] [Abstract][Full Text] [Related]
5. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children.
Goldman CG; Barrado DA; Balcarce N; Rua EC; Oshiro M; Calcagno ML; Janjetic M; Fuda J; Weill R; Salgueiro MJ; Valencia ME; Zubillaga MB; Boccio JR
Nutrition; 2006 Oct; 22(10):984-8. PubMed ID: 16978844
[TBL] [Abstract][Full Text] [Related]
6. Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection.
Yoon H; Kim N; Kim JY; Park SY; Park JH; Jung HC; Song IS
J Gastroenterol Hepatol; 2011 Jan; 26(1):44-8. PubMed ID: 21175792
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection.
Lim JH; Lee DH; Lee ST; Kim N; Park YS; Shin CM; Song IS
World J Gastroenterol; 2015 Dec; 21(46):13124-31. PubMed ID: 26673999
[TBL] [Abstract][Full Text] [Related]
8. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
Kim MN; Kim N; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Kim JS; Jung HC; Song IS
Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
[TBL] [Abstract][Full Text] [Related]
9. Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy.
Kao AW; Cheng HC; Sheu BS; Lin CY; Sheu MJ; Yang HB; Wu JJ
J Gen Intern Med; 2005 Feb; 20(2):139-42. PubMed ID: 15836546
[TBL] [Abstract][Full Text] [Related]
10. Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora.
Wang YH; Huang Y
World J Microbiol Biotechnol; 2014 Mar; 30(3):847-53. PubMed ID: 24233772
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation.
Efrati C; Nicolini G; Cannaviello C; O'Sed NP; Valabrega S
World J Gastroenterol; 2012 Nov; 18(43):6250-4. PubMed ID: 23180945
[TBL] [Abstract][Full Text] [Related]
12. Phytomedicine-based and Quadruple Therapies in Helicobacter pylori Infection: A Comparative, Randomized Trial.
Asif HM; Zaidi SF; Sugiyama T; Akhtar N; Usmanghani K
Altern Ther Health Med; 2015; 21 Suppl 2():33-9. PubMed ID: 26308758
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.
Medeiros JA; Gonçalves TM; Boyanova L; Pereira MI; de Carvalho JN; Pereira AM; Cabrita AM
Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):555-9. PubMed ID: 21207091
[TBL] [Abstract][Full Text] [Related]
14. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.
Poonyam P; Chotivitayatarakorn P; Vilaichone RK
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388
[TBL] [Abstract][Full Text] [Related]
15. Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.
Xie Y; Zhu Y; Zhou H; Lu ZF; Yang Z; Shu X; Guo XB; Fan HZ; Tang JH; Zeng XP; Wen JB; Li XQ; He XX; Ma JH; Liu DS; Huang CB; Xu NJ; Wang NR; Lu NH
World J Gastroenterol; 2014 Aug; 20(32):11415-21. PubMed ID: 25170230
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea.
Kang KK; Lee DH; Oh DH; Yoon H; Shin CM; Park YS; Kim N; Jung HC
World J Gastroenterol; 2014 Jun; 20(22):6932-8. PubMed ID: 24944485
[TBL] [Abstract][Full Text] [Related]
17. Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
Yang J; Zhang Y; Fan L; Zhu YJ; Wang TY; Wang XW; Chen DF; Lan CH
Am J Gastroenterol; 2019 Mar; 114(3):437-445. PubMed ID: 30807294
[TBL] [Abstract][Full Text] [Related]
18. Eradication Rate of
Liu RP; Romero R; Sarosiek J; Dodoo C; Dwivedi AK; Zuckerman MJ
South Med J; 2018 Jan; 111(1):51-55. PubMed ID: 29298370
[TBL] [Abstract][Full Text] [Related]
19. Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S
Asian Pac J Cancer Prev; 2015; 16(12):4885-90. PubMed ID: 26163609
[TBL] [Abstract][Full Text] [Related]
20. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
Mirbagheri SA; Hasibi M; Abouzari M; Rashidi A
World J Gastroenterol; 2006 Aug; 12(30):4888-91. PubMed ID: 16937475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
